The Hepatocellular Carcinoma (HCC) Drugs Market has emerged as one of the fastest-growing segments within the global oncology therapeutics industry. Hepatocellular carcinoma, the most common type of primary liver cancer, accounts for nearly 80–90% of all liver cancer cases worldwide. The rising incidence of chronic liver diseases, hepatitis B and C infections,...

"Executive Summary Immuno-Oncology (IO) Market Size and Share Analysis Report Data Bridge Market Research analyses that the immuno-oncology (IO) market, which is USD 28.10 billion in 2022, is expected to reach USD 156.05 billion by 2030, at a CAGR of 23.9% during the forecast period 2023 to 2030. Accomplishment of maximum return on investment (ROI) is one of the most wannabe goals for any...